Evidence map›Paper›PMID 33311484›Full record

ArticleNature communications2020

A meta-learning approach for genomic survival analysis.

Yeping Lina Qiu, Hong Zheng, Arnout Devos, Heather Selby, Olivier Gevaert

Abstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. An Interpretable Omics-to-Image Transformer Framework for Cancer Prognosis Prediction.Computational and structural biotechnology journal · 2026
    Article
  8. Article
  9. Article
  10. AHDSN: an attention-enabled hybrid deep sequential network for cancer survivability prediction from multi-omics data.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yeping Lina QiuDepartment of Electrical Engineering, Stanford University, Stanford, USA.
Hong ZhengDepartment of Medicine, Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, USA.ORCID 0000-0002-8884-8211
Arnout DevosSchool of Computer and Communication Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.ORCID 0000-0002-9425-1163
Heather SelbyDepartment of Medicine, Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, USA.
Olivier GevaertDepartment of Medicine, Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, USA. ogevaert@stanford.edu.ORCID 0000-0002-9965-5466

Funding

Radiogenomics Framework for Non-Invasive Personalized MedicineR01EB020527 · NIBIB · STANFORD UNIVERSITY · PI GEVAERT, OLIVIER · 2015 to 2018
$2.3M
Inhibitors of the G protein GNAS which drives pancreatic tumorigenesisR01CA244550 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SHOKAT, KEVAN M. · 2020 to 2024
$2.0M
Radiogenomics framework for non-invasive personalized medicineR56EB020527 · NIBIB · STANFORD UNIVERSITY · PI GEVAERT, OLIVIER · 2019 to 2019
$444k
NCI NIH HHS R01 CA244550NIBIB NIH HHS R01 EB020527NIBIB NIH HHS R56 EB020527
6 · The paper itself

Abstract

RNA sequencing has emerged as a promising approach in cancer prognosis as sequencing data becomes more easily and affordably accessible. However, it remains challenging to build good predictive models especially when the sample size is limited and the number of features is high, which is a common situation in biomedical settings. To address these limitations, we propose a meta-learning framework based on neural networks for survival analysis and evaluate it in a genomic cancer research setting. We demonstrate that, compared to regular transfer-learning, meta-learning is a significantly more effective paradigm to leverage high-dimensional data that is relevant but not directly related to the problem of interest. Specifically, meta-learning explicitly constructs a model, from abundant data of relevant tasks, to learn a new task with few samples effectively. For the application of predicting cancer survival outcome, we also show that the meta-learning framework with a few samples is able to achieve competitive performance with learning from scratch with a significantly larger number of samples. Finally, we demonstrate that the meta-learning model implicitly prioritizes genes based on their contribution to survival prediction and allows us to identify important pathways in cancer.

Indexed as

Machine LearningAlgorithmsComputational BiologyGenomicsHumansNeoplasmsNeural Networks, ComputerPrognosisSurvival Analysis

Identifiers

PMID33311484
PMCPMC7733508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.